Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Absence of progression as assessed by response evaluation criteria in solid tumors predicts survival in advanced GI stromal tumors treated with imatinib mesylate: the intergroup EORTC-ISG-AGITG phase III trialAxel Le Cesne, Martine Van Glabbeke, Jaap Verweij, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 20, 2025
Proton pump inhibition to prevent delayed chemotherapy-induced nausea and vomiting in patients receiving adjuvant or neoadjuvant breast cancer chemotherapy: a phase II, randomised double-blind crossover trial (PantoCIN)Navin Wewala, Yujin Kim, Katrina Sharples, et al.
Nature Communications|June 22, 2016
Microfluidic single-cell transcriptional analysis rationally identifies novel surface marker profiles to enhance cell-based therapiesRobert C Rennert, Michael Januszyk, Michael Sorkin, et al.
Annals of Surgical Oncology|March 25, 2017
TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTGTrevor Leong, B Mark Smithers, Karin Haustermans, et al.
Internal Medicine Journal|July 6, 2021
Clinical characteristics and outcomes of COVID-19 in a low-prevalence, well resourced setting, Sydney, AustraliaEmily Shiel, Spiros Miyakis, Elaine Tennant, et al.
The Lancet. Oncology|August 8, 2017
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trialsHarpreet S Wasan, Peter Gibbs, Navesh K Sharma, et al.
The New England Journal of Medicine|September 16, 2024
Preoperative Chemoradiotherapy for Resectable Gastric CancerTrevor Leong, B Mark Smithers, Michael Michael, et al.
NPJ Genomic Medicine|August 1, 2018
Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancerBen Lawrence, Cherie Blenkiron, Kate Parker, et al.
Pageof 5